We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1359:HKEXChina Cinda Asset Management Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

HK$1.15

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The share price is trading below all key short‑term moving averages, and the MACD histogram remains in negative territory, signalling a bearish momentum. RSI is perched in the low‑30s, hinting at modest oversold pressure but not a clear reversal signal. Volume has been picking up, yet the price is still confined between a clear support level near the low end of its recent range and a resistance that remains well above current levels. The 30‑day volatility is elevated, and the historical maximum drawdown exceeds 30%, underscoring the price’s susceptibility to sharp swings. Sentiment is tilted toward greed on the fear‑greed index, but the low beta suggests the stock moves less than the broader market, tempering systematic risk.
Fundamental backdrop: Valuation metrics show a price‑to‑earnings multiple that sits above the industry average, while the price‑to‑book ratio is exceptionally low, indicating a potential discount relative to book value. The dividend yield is modest yet the payout ratio stays under 50%, raising questions about long‑term sustainability given a very low return on equity and a heavily leveraged balance sheet. Recent corporate disclosures reveal regulatory approval for a new president and tightened audit committee rules, suggesting improved governance but also highlighting ongoing regulatory scrutiny. The discounted cash‑flow model points to a sizable upside, and the upside/downside estimate aligns with a roughly 30% upside potential, reinforcing the case for a value‑oriented investment thesis.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators with price below key averages
  • Proximity to support limits upside potential
  • Regulatory approval for new leadership reduces immediate uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation gap between market price and book value
  • Attractive dividend yield relative to peers
  • Upside potential indicated by DCF and upside/downside estimate

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Fundamental undervaluation and potential asset recovery
  • Improved governance structures after recent board changes
  • Sustainable dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth16.10%
Profit Margin12.88%
P/E Ratio19.2
ROE0.80%
ROA0.11%
Debt/Equity434.44
P/B Ratio0.2
Op. Cash FlowHK$78.3B
Industry P/E16.4

Technical Analysis

TrendBearish
RSI33.4
SupportHK$1.14
ResistanceHK$1.31
MA 20HK$1.22
MA 50HK$1.26
MA 200HK$1.32
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueHK$27.79
Target PriceHK$1.47
Upside/Downside28.25%
GradeUndervalued
TypeValue
Dividend Yield2.27%

Risk Assessment

Beta0.29
Volatility35.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.